Business Context and Reporting Period
This Form 6-K is filed by Fresenius Medical Care AG & Co. KGaA for the month of June 2007. The report serves as a supplement to a previous filing dated May 4, 2007, regarding ongoing investigations in the Eastern District of Missouri.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document focuses exclusively on legal contingencies rather than financial performance data.
Material Changes
There are no reported material changes to financial results. The material update concerns the status of a legal investigation involving Renal Care Group, Inc. ("RCG").
Guidance, Risks, and Contingencies
- Legal Investigation: The U.S. Attorney's office for the Eastern District of Missouri may file a civil complaint against RCG regarding issues arising from the operation of RCG's Method II supply company.
- Company Position: Fresenius Medical Care believes RCG's operations were in compliance with applicable law and intends to defend any litigation vigorously while continuing to cooperate with the investigation.
- Risk Assessment: Management states that an adverse determination in this investigation, or any resulting litigation or settlement, could have a material adverse effect on the Company's business, financial condition, and results of operations.
Key Facts for Investor Verification
- Verify the current status of the U.S. Attorney's investigation into RCG's Method II supply company.
- Monitor for the potential filing of a civil complaint against RCG by the Eastern District of Missouri.
- Assess the potential financial impact of an adverse legal determination or settlement on Fresenius Medical Care's operations.